Capital Bank & Trust’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-18
Closed -$1K 401
2020
Q1
$1K Sell
18
-2
-10% -$162 ﹤0.01% 662
2019
Q4
$2K Hold
20
﹤0.01% 670
2019
Q3
$2K Hold
20
﹤0.01% 706
2019
Q2
$2K Buy
+20
New +$2.02K ﹤0.01% 637

Other funds holding EXAS

Capital Bank & Trust's EXAS Position: Q2 2020 in Review

Capital Bank & Trust sold out of Exact Sciences (EXAS) in Q2 2020, closing a stake of 18 shares — an estimated $1K sold.

Capital Bank & Trust first reported a position in EXAS in Q2 2019 and held it in 4 quarters. The position peaked at $2K in Q4 2019. 513 funds tracked by Wall St. Rank hold EXAS as of Q2 2020.

  • Capital Bank & Trust reported no remaining Exact Sciences position as of Q2 2020 after selling out during the quarter.
  • Capital Bank & Trust sold 18 Exact Sciences shares in Q2 2020, an estimated $1K.
  • Capital Bank & Trust first reported a position in Exact Sciences in Q2 2019 and held it in 4 quarters.
  • Capital Bank & Trust's Exact Sciences position peaked at $2K in Q4 2019.
  • 513 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2020.

Based on Capital Bank & Trust's 13F filing for Q2 2020, filed 14 Aug 2020.